The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

NCCN awards grants to five young investigators

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS
Rebecca Arend
Yin Cao
Tim Luetkens
Edwin Manuel
Cecilia Yeung

The NCCN Foundation has announced five recipients for this year’s Young Investigator Awards. The grantees come from National Comprehensive Cancer Network Member Institutions, and will each receive up to $150,000 in funding over a two-year period.

This marks the eighth year for the NCCN Foundation Young Investigator Awards supporting career development for innovative cancer researchers.

The 2018 awardees are:

Rebecca Arend, University of Alabama at Birmingham Comprehensive Cancer Center

The Role of TGF-β in Immune Suppression in Suboptimally Debulked Ovarian Cancer Patients

Yin Cao, Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

Disparities in Young-Onset Colorectal Cancer Survival According to Patient, Treatment, and Tumor Molecular Characteristics

Tim Luetkens, Huntsman Cancer Institute at the University of Utah

CD229 Chimeric Antigen Receptor T Cells for the Treatment of Multiple Myeloma

Edwin Manuel, City of Hope Comprehensive Cancer Center

Altering the Local Immune Landscape in Lung Cancer to Improve Anti-PD-1 Therapy

Cecilia Yeung, Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

Optimization of a Rapid Point of Care Device for Acute Promyelocytic Leukemia Diagnosis and Therapy Guidance

These five awardees were selected out of a pool of 48 applicants nominated from across the 27 NCCN member institutions. The NCCN Oncology Research Program will manage and oversee the projects for the next two years. The awardees will then present the results from their research at the NCCN 25th Annual Conference in 2020.

Table of Contents

YOU MAY BE INTERESTED IN

Clinical

Oncofertility coverage mandates expand to 21 states and DC as political momentum builds
Gaps persist as patients face harrowing decisions and huge copays

The nagging pain in Mia Sandino’s right knee set in in September 2018, and throughout her freshman year at the University of Washington, she tried to ignore it. “I was being a very naive and invincible-feeling 19-year-old,” Sandino told The Cancer Letter. “I didn’t put two and two together that this area of the knee that...

By Claire Marie Porter and Sara Willa Ernst
Guest Editorial

My introduction to, and lessons learned from, Rick Pazdur

Rick Pazdur, MD, the newly appointed director for the Center for Drug Evaluation and Research at the FDA, has been described as “greyhound thin” as a result of his dedication to cycling and lifting weights in the gym each day and, for a long time, a vegetarian diet. I first met him when he was the director of the Office of Oncology Drug Products (ODP) within CDER, in 2009.
By Mikkael A. Sekeres
Sponsored

Meeting the moment: ASCO GI Cancers Symposium delivers insights and collaboration

When it comes to fighting cancer today, collaboration is key. At a time when funding is uncertain, yet innovative breakthroughs are accelerating every day, it’s more important than ever for oncologists, scientists, academic researchers, and community physicians, to come together to share knowledge and gain insights about the forefront of cancer research.
By The American Society of Clinical Oncology
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account